Sage Journals: Discover world-class research

Free access

Research article

First published 2021-8

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients

Keatdamrong Janpipatkul, Narumol Trachu, Piyakarn Watcharenwong [...]

Cancer Biomarkers

Open access

Review article

First published 2022

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

Jiyun Lee, Zofia Piotrowska, Ross Soo [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness,Resistance Mechanisms,and Prognosis of Different Subsequent Treatments

Naifu Nie, Jianghua Li, Jian Zhang [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2024

BLU-945,a potent and selective next-generation EGFR TKI,has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer

Sun Min Lim, Stefanie S. Schalm, Eun Ji Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2020-6

Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib

Xiaohui Ren, Xinfeng Cai, Jing Li [...]

Journal of International Medical Research

Open access

Research article

First published 2022

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Sun Min Lim, San-Duk Yang, Sangbin Lim [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells

Eun-Ju Ko, Eun-Bin Kwag, Ji-Hye Park [...]

Integrative Cancer Therapies

Open access

Research article

First published 2020

Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment

Julie A. Vendrell, Xavier Quantin, Isabelle Serre [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2017-6

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale,evidence and place in therapy

Biagio Ricciuti, Sara Baglivo, Luca Paglialunga [...]

Therapeutic Advances in Medical Oncology

Retricted access

Letter

First published 2022-4

Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC

Jessica Freydman, Lynnette Henshaw, Jasmine V. Patel [...]

Annals of Pharmacotherapy

Search results